Review of recent studies on interventions for cognitive deficits in patients with cancer

Research output: Contribution to journalArticleScientificpeer-review

Abstract

Research has demonstrated that patients with cancer experience cognitive deficits, often due to aggressive anticancer treatments. In this article, we critically review the interventional studies that have been conducted to investigate beneficial effects on cognitive function in cancer patients. Pharmacological agents that have been studied include psychostimulants, such as methylphenidate and modafinil, erythropoietin, and hormonal (supplement) treatments for patients who receive hormonal suppression therapy. In addition, several cognitive rehabilitation programs have been evaluated in cancer patients. Recently, the approach of physical exercise to treat cognitive deficits has received great interest, and findings from novel studies are keenly anticipated. Although, in general, the studies reviewed were well designed, future studies may wish to include larger sample sizes and pay more attention to the accurate assessment of cognitive function.
Original languageEnglish
Pages (from-to)255-269
JournalExpert Review of Anticancer Therapy
Volume12
Issue number2
DOIs
Publication statusPublished - 2012

Fingerprint

Neoplasms
Exercise
modafinil

Cite this

@article{e5af83be245d43368c7e711727b6f367,
title = "Review of recent studies on interventions for cognitive deficits in patients with cancer",
abstract = "Research has demonstrated that patients with cancer experience cognitive deficits, often due to aggressive anticancer treatments. In this article, we critically review the interventional studies that have been conducted to investigate beneficial effects on cognitive function in cancer patients. Pharmacological agents that have been studied include psychostimulants, such as methylphenidate and modafinil, erythropoietin, and hormonal (supplement) treatments for patients who receive hormonal suppression therapy. In addition, several cognitive rehabilitation programs have been evaluated in cancer patients. Recently, the approach of physical exercise to treat cognitive deficits has received great interest, and findings from novel studies are keenly anticipated. Although, in general, the studies reviewed were well designed, future studies may wish to include larger sample sizes and pay more attention to the accurate assessment of cognitive function.",
author = "K. Gehring and J.A. Roukema and M.M. Sitskoorn",
year = "2012",
doi = "10.1586/era.11.202",
language = "English",
volume = "12",
pages = "255--269",
journal = "Expert Review of Anticancer Therapy",
issn = "1473-7140",
publisher = "Expert Reviews Ltd.",
number = "2",

}

Review of recent studies on interventions for cognitive deficits in patients with cancer. / Gehring, K.; Roukema, J.A.; Sitskoorn, M.M.

In: Expert Review of Anticancer Therapy, Vol. 12, No. 2, 2012, p. 255-269.

Research output: Contribution to journalArticleScientificpeer-review

TY - JOUR

T1 - Review of recent studies on interventions for cognitive deficits in patients with cancer

AU - Gehring, K.

AU - Roukema, J.A.

AU - Sitskoorn, M.M.

PY - 2012

Y1 - 2012

N2 - Research has demonstrated that patients with cancer experience cognitive deficits, often due to aggressive anticancer treatments. In this article, we critically review the interventional studies that have been conducted to investigate beneficial effects on cognitive function in cancer patients. Pharmacological agents that have been studied include psychostimulants, such as methylphenidate and modafinil, erythropoietin, and hormonal (supplement) treatments for patients who receive hormonal suppression therapy. In addition, several cognitive rehabilitation programs have been evaluated in cancer patients. Recently, the approach of physical exercise to treat cognitive deficits has received great interest, and findings from novel studies are keenly anticipated. Although, in general, the studies reviewed were well designed, future studies may wish to include larger sample sizes and pay more attention to the accurate assessment of cognitive function.

AB - Research has demonstrated that patients with cancer experience cognitive deficits, often due to aggressive anticancer treatments. In this article, we critically review the interventional studies that have been conducted to investigate beneficial effects on cognitive function in cancer patients. Pharmacological agents that have been studied include psychostimulants, such as methylphenidate and modafinil, erythropoietin, and hormonal (supplement) treatments for patients who receive hormonal suppression therapy. In addition, several cognitive rehabilitation programs have been evaluated in cancer patients. Recently, the approach of physical exercise to treat cognitive deficits has received great interest, and findings from novel studies are keenly anticipated. Although, in general, the studies reviewed were well designed, future studies may wish to include larger sample sizes and pay more attention to the accurate assessment of cognitive function.

U2 - 10.1586/era.11.202

DO - 10.1586/era.11.202

M3 - Article

VL - 12

SP - 255

EP - 269

JO - Expert Review of Anticancer Therapy

JF - Expert Review of Anticancer Therapy

SN - 1473-7140

IS - 2

ER -